Bentham Science Logo

Clinical Cancer Drugs (Discontinued)

Volume 9, 2 Issues, 2022
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access

Contents

Clinical Cancer Drugs , Volume 7 - Number 2






Review Article (Mini-Review)

Does the Oxazolidinone Derivatives Constitute a Functional Approach for Cancer Therapy?

, 7(2): 95 - 106

Eduardo Augusto Vasconcelos de Freitas Ramalho*, Marina Galdino da Rocha Pitta, Hernando de Barros Siqueira Neto and Ivan da Rocha Pitta


DOI: 10.2174/2212697X07999200807210936



Research Article

Alsevirone-NF Reduces Serum Testosterone and Inhibits Prostate Cancer Xenograft Growth in Balb/c Nude Mice

, 7(2): 113 - 118

Vadim S. Pokrovsky*, Vladimir A. Zolottsev, Alexandra S. Latysheva, Vasiliy A. Kudinov, Natalia Yu Anisimova, R.L.M. Almanza, Olga Yu Alekseeva, Konstantin K. Baskaev, Galina B. Smirnova, Yulia A. Borisova and Olga M. Ipatova


DOI: 10.2174/2212697X07999200511082225



Clinical Trial

A Phase I Study of OMN54 (Aneustat™) in Patients with Advanced Malignancies

, 7(2): 125 - 132

Karen A. Gelmon*, Christian Kollmannsberger, Stephen Chia, Anna V. Tinker, Teresa Mitchell, Stephen Lam, Teresa Joshi, David Kwok, John Ostrem, Simon Sutcliffe and Daniel J. Renouf


DOI: 10.2174/1574893615999200601130946




Editor-in-Chief

Giulio Francia
Department of Biological Sciences
The University of Texas
El Paso, TX
(USA)
Biography
View Full Editorial Board

For Librarians & Readers

Quick Links

Related Journals

Related eBooks

eBooks Catalog